Ando K, Okada Y, Akiba M, Kondo T, Kawamura T, Okumura M, Chen F, Date H, Shiraishi T, Iwasaki A, Yamasaki N, Nagayasu T, Chida M, Inoue Y, Hirai T, Seyama K, Mishima M and the Respiratory Failure Research Group of the Japanese Ministry of Health, Labour, and Welfare. Lung transplantation for lymphangioleiomyomatosis in Japan. PLos One 2016; 11(1): e0146749.
Fujita A, Ando K, Kobayashi E, Mitani K, Okudera K, Nakashima M, Miyatake S, Tsurusaki Y, Saitsu H, Seyama K, Miyake N, Matsumoto N. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing. Hum Genet. 2016,135(1):61-8.
Gunji-Niitsu Y, Kumasaka T, Kitamura S, Hoshika Y, Hayashi T, Tokuda H, Morita R, Kobayashi E, Mitani K, Kikkawa M, Takahashi K, Seyama K. Benign clear cell sugar tumor of the lung in a patient with Birt-Hogg-Dub? syndrome: a case report. BMC Med Genet. 2016,17(1):85.
Jotatsu, T., Yagishita, S., Tajima, K., Takahashi, F., Mogushi, K., Hidayat, M., Wirawan, A., Ko, R., Kanemaru, R., Shimada, N., Mitani, K., Saito, T., Takamochi, K., Suzuki, K., Kohsaka, S., Kojima, S., Mukae, H., Yatera, K., and Takahashi, K.LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer. Biochemical and biophysical research communications. 2016;473(1):125-132. Kato M, Sasaki S, Sekimoto Y, Arano N, Jo H, Suina K, Kuriyama S, Muraki K, Nagashima O, Yoshioka Y, Tominaga S, Takahashi K. Loxoprofen-induced interstitial pneumonia: a case report. J Med Case Rep. 2016,10(1):128.
Ko R, Kenmotsu H, Serizawa M, Koh Y, Wakuda K, Ono A, Taira T, Naito T, Murakami H, Isaka M, Endo M, Nakajima T, Ohde Y, Yamamoto N, Takahashi K, Takahashi T Frequency of EGFR T790M mutatoin and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tryosine kinase inhibitors in Japanese patients BMC cancer, 2016; 16(1): 864
Kobayashi I, Takahashi F, Nurwydia F, Nara T, Hashimoto M, Murakami A, Yagishita S, Tajima K, Hidayat M, Shimada N, Suina K, Yoshioka Y, Sasaki S, Moriyama M, Moriyama H, Takahashi K. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells. Biochem Biophys Res Commun. 2016,22;473(1):125-32.
Koyama R, Takahashi K. Non-Small-Cell lung cancer treatment: cytotoxic chemotherapy, molecular targeted therapy, and immunotherapy. Juntendo Medical Journal,2016, 62(1): 7-12.
Kato M, Morio Y, Matsunaga T, Shiraishi A, Uekusa T, Takahashi K. Bronchial-pulmonary arterial fistula with primary racemose hemangioma. Respirol Case Rep. 2016,4(2):e00148.
Nurwidya F, Takahashi F, Takahashi K. Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation. J Nat Sci Biol Med. 2016,7(2):119-23.
Sekimoto Y, Kato M, Shukuya T, Koyama R, Nagaoka T, Takahashi K. Bevacizumab-induced chronic interstitial pneumonia during maintenance therapy in non-small cell lung cancer. Respirol Case Rep. 2016 ,4(2):e00151.
Ebana H, Otsuji M, Mizobuchi T, Kurihara M, Takahashi K, Seyama K. Pleural Covering Application for Recurrent Pneumothorax in a Patient with Birt-Hogg-Dub? Syndrome. Ann Thorac Cardiovasc Surg.2016, 22(3):189-92.
Fukui M, Takamochi K, Matsunaga T, Oh S, Ando K, Suzuki K, Arakawa A, Uekusa T, Suzuki K. Risk of the preoperative underestimation of tumour size of lung cancer in patients Hayashida M, Yasuo M, Hanaoka M, Seyama K, Inoue Y, Tatsumi K, Mishima M; Respiratory Failure Research Group of the Ministry of Health, Labour, and Welfare, Japan. Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: An analysis of the Japanese National Research Project on Intractable Diseases database. Respir Investig. 2016,54(3):193-200.
Ebana H, Otsuji M, Mizobuchi T, Kurihara M, Takahashi K, Seyama K. Pleural Covering Application for Recurrent Pneumothorax in a Patient with Birt-Hogg-Dub? Syndrome. Ann Thorac Cardiovasc Surg. 2016,22(3):189-92.
Sakurai F, Narii N, Tomita K, Togo S, Takahashi K, Machitani M, Tachibana M, Ouchi M, Katagiri N, Urata Y, Fujiwara T, Mizuguchi H. Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus. Mol Ther Methods Clin Dev. 2016,3:16001.
Sawada T, Watanabe M, Fujimura Y, Yagishita S, Shimoyama T, Maeda Y, Kanda S, Yunokawa M, Tamura K, Tamura T, Minami H, Koh Y, Koizumi F. Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells. Cancer Sci. 2016,107(3):307-14.
Seyama K, Hirai T, Mishima M, Tatsumi K, Nishimura M; Respiratory Failure Research Group of the Japanese Ministry of Health, Labour, and Welfare. A nationwide epidemiological survey of alpha1-antitrypsin deficiency in Japan. Respir Investig. 2016,54(3):201-6.
Yamada K, Ichiki M, Takahashi K, Hisamatsu Y, Takeoka H, Azuma K, Shukuya T, Nishikawa K, Tokito T, Ishii H, Hoshino T. A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer Cancer Chemother Pharmacol. 2016,78(3):501-7.
Yoshimi K, Oh S, Suzuki K, Kodama Y, Sekiya M, Seyama K, Fukuchi Y. Impact of Airflow Limitation on Comorbidities and Postoperative Complications in Patients Undergoing Thoracic Surgery: A Retrospective Observationa Ann Thorac Cardiovasc Surg. 2016,22(3):146-52.
Hoshika Y, Takahashi F, Togo S, Hashimoto M, Nara T, Kobayashi T, Nurwidya F, Kataoka H, Kurihara M, Kobayashi E, Ebana H, Kikkawa M, Ando K, Nishino K, Hino O, Takahashi K, Seyama K. Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dub? syndrome. Physiol Rep. 2016,4(21). pii: e13025.
Kato M, Sasaki S, Izumi H, Uekusa T, Tominaga S, Takahashi K. Development of diffuse alveolar damage after initiation of Nijutsuto. Respirol Case Rep. 2016,25;4(6):e00195.
Ando K, Nakashita T, Kaneko N, Takahashi K, Motojima S. Associations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease severity. Springer Plus 2016,5: 1401.
Nakashita T, Ando K, Takahashi K, Motojima S. Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients. Respiratory Investigation. 2016,54(5): 376-379.
Comaills V, Kabeche L, Morris R, Buisson R, Yu M, Madden MW, LiCausi JA, Boukhali M, Tajima K, Pan S, Aceto N, Sil S, Zheng Y, Sundaresan T, Yae T, Jordan NV, Miyamoto DT, Ting DT, Ramaswamy S, Haas W, Zou L, Haber DA, Maheswaran S Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition Cell Rep. 2016,6;17(10):2632-2647
McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, Steagall WK, Johnson SR, Sahn SA, Ryu JH, Strange C, Seyama K, Sullivan EJ, Kotloff RM, Downey GP, Chapman JT, Han MK, D'Armiento JM, Inoue Y, Henske EP, Bissler JJ, Colby TV, Kinder BW, Wikenheiser-Brokamp KA, Brown KK, Cordier JF, Meyer C, Cottin V, Brozek JL, Smith K, Wilson KC, Moss J; ATS/JRS Committee on LymphangioleiomyomatosisOfficial American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. Am J Respir Crit Care Med. 2016,15;194(6):748-61
Shigematsu, M., T. Koga, A. Ishimori, K. Saeki, Y. Ishii, Y. Taketomi, M. Ohba, A. Jo-Watanabe, T. Okuno, N. Harada, T. Harayama, H. Shindou, J. D. Li, M. Murakami, S. Hoka, and T. Yokomizo. Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury. Sci Rep, 2016; 6: 34560.
Shigeru Tominaga Clinic-based lung cancer screening in Urayasu Juntendo Medical Journal 2016;62(6):455-459.
Ishimori A, Harada N, Chiba A, Harada S, Matsuno K, Makino F, Ito J, Ohta S, Ono J, Atsuta R, Izuhara K, Takahashi K, Miyake S. Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are associated with airflow limitation in patients with asthma. Allergol Int. 2016 Aug 26.
Hishida T, Miyaoka E, Yokoi K, Tsuboi M, Asamura H, Kiura K, Takahashi K, Dosaka-Akita H, Kobayashi H, Date H, Tada H, Okumura M, Yoshino I. Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis. J Thorac Oncol. 2016,11(9):1529-37.
Jiang L, Konishi H, Nurwidya F, Takahashi F, Ebinuma H, Fujimura K, Takasu K, Jiang M, Bujo H, Daida H. Deletion of smooth muscle cell migration regulator LR11 attenuates the hypoxia- induced pulmonary arterial remodeling with medial thickening in mice. Arterioscler Thromb Vasc Biol 2016,36(9):1972-9.
Kurihara M, Mizobuchi T, Kataoka H, Sato T, Kumasaka T, Ebana H, Yamanaka S, Endo R, Miyahashira S, Shinya N, Seyama K. A Total Pleural Covering for Lymphangioleiomyomatosis Prevents Pneumothorax Recurrence. PLoS One. 2016,22;11(9):e0163637
Ando K, Fujino N, Mitani K, Ota C, Okada Y, Kondo T, Mizobuchi T, Kurihara M, Suzuki K, Hoshika Y, Ebana H, Kobayashi E, Takahashi K, Kubo H, Seyama K. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis. Am J Physiol Lung Cell Mol Physiol. 2016;310(10):L899-908.
Kato M, Shukuya T, Mori K, Kanemaru R, Honma Y, Nanjo Y, Muraki K, Shibayama R, Koyama R, Shimada N, Takahashi F, Takahashi K. Cerebral infarction in advanced non-small cell lung cancer: a case control study. BMC Cancer. 2016,10;16:203.
Okuma HS, Horinouchi H, Kitahara S, Asao T, Sunami K, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Ohe Y. Comparison of amrubicin and weekly cisplatin/etoposide/irinotecan in patients with relapsed small-cell lung cancer. Clin Lung Cancer 2016 Oct 25.
Shukuya T, Mori K, Amann JM, Bertino EM, Otterson GA, Shields PG, Morita S, Carbone DP. Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Antibodies. J Thorac Oncol. 2016,11(11):1927-1939.
Takada T, Mikami A, Kitamura N, Seyama K, Inoue Y, Nagai K, Suzuki M, Moriyama H, Akasaka K, Tazawa R, Hirai T, Mishima M, Hayashida M, Hirose M, Sugimoto C, Arai T, Hattori N, Watanabe K, Tamada T, Yoshizawa H, Akazawa K, Tanaka T, Yagi K, Young LR, McCormack FX, Nakata K. Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis. Ann Am Thorac Soc. 2016,13(11):1912-1922.
Asao T, Fujiwara Y, Itahashi K, Kitahara S, Goto Y, Horinouchi H, Kanda S, Nokihara H, Yamamoto N, Ohe Y. Sequential use of anaplastic lymphoma kinase inhibitors in Japanese patients with ALK-rearranged non-small-cell lung cancer Sequential use of anaplastic lymphoma kinase inhibitors in Japanese patients with ALK-rearranged non-small-cell lung cancer: A retrospective analysis. Clin Lung Cancer 2016 Dec 7
Hashimoto M, Asai A, Kawagishi H, Mikawa R, Iwashita Y, Kanayama K, Sugimoto K, Sato T, Maruyama M, Sugimoto M. Elimination of p19ARF-expressing cells enhances pulmonary function in mice JCI Insight, 2016;1(12):e87732
Yamane Y, Shiono A, Ishii Y, Isobe K, Miyauchi E, Kishi K, Nishino M, Sugawara S, Ko R, Koyama N, Yabuki Y, Kobayashi K Treatment and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan Jpn J Clin Oncol, 2016,46(12): 1135-1142
Atsuta R, To Y, Sakamoto S, Mukai I, Kobayashi A, Kinoshita A, Takahashi K. Assessing usability of the Adherence Starts with Knowledge 20 (ASK-20) questionnaire for Japanese adults with bronchial asthma receiving inhaled corticosteroids long term. Allergol Int. pii: S1323-8930(16)30150-2, 2016.
Hayashi T, Kumasaka T, Mitani K, Okada Y, Kondo T, Date H, Chen F, Oto T, Miyoshi S, Shiraishi T, Iwasaki A, Hara K, Saito T, Ando K, Kobayashi E, Gunji-Niitsu Y, Kunogi M, Takahashi K, Yao T, Seyama K. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses. Hum Pathol. 2016,50:34-42.
Katsuya Y, Horinouchi H, Asao T, Kitahara S, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Watanabe S, Tsuta K, Ohe Y. Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy. Lung Cancer 2016; 99: 4-10.
Kentaro Suina , Takehito Shukuya, , Ryo Koyama , Tetsuhiko Asao , Yuichiro Honma , Motoyasu Kato , Keiko Muraki , Rina Shibayama , Naoko Shimada , Fumiyuki Takahashi , Shoko Sakuraba , Kazuhisa Takahashi Risk factors for serious adverse events due to cytotoxic chemotherapy for advanced non-small cell lung cancer. Cancer Treatment and Research Communications 2016;19:106
Kodama Y, Kishimoto Y, Muramatsu Y, Tatebe J, Yamamoto Y, Hirota N, Itoigawa Y, Atsuta R, Koike K, Sato T, Aizawa K, Takahashi K, Morita T, Homma S, Seyama K, Ishigami A Antioxidant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease (COPD), asthma-COPD overlap syndrome, and bronchial asthma. The Clinical Respiratory Journal2016 ISSN 1752-6981
